{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:05:15Z","timestamp":1792008315457,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"vor","delay-in-days":379,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jacc.2017.06.030","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T15:31:15Z","timestamp":1502119875000},"page":"813-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Biomarker-Based Risk Model to Predict\u00a0Cardiovascular Mortality in Patients\u00a0With\u00a0Stable\u00a0Coronary\u00a0Disease"],"prefix":"10.1016","volume":"70","author":[{"given":"Daniel","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lindb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Budaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ollie","family":"\u00d6stlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.H.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Soffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert J.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Siegbahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus E.","family":"Kleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dressel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja B.","family":"Grammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.06.030_bib1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.06.030_bib2","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20142017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.06.030_bib3","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib4","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/eurheartj\/eht533","article-title":"Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients","volume":"35","author":"Rapsomaniki","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.06.030_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(01)01360-2","article-title":"Long-term risk stratification for survivors of acute coronary syndromes: results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) study","volume":"38","author":"Marschner","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.06.030_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2007.03.038","article-title":"Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial","volume":"50","author":"Omland","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa042330","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease","volume":"352","author":"Kragelund","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib12","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A\u00a0sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/eurheartj\/ehi036","article-title":"Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study","volume":"26","author":"Schnabel","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.06.030_bib14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1415921","article-title":"Troponin and cardiac events in stable ischemic heart disease and diabetes","volume":"373","author":"Everett","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.carrev.2014.02.003","article-title":"Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy","volume":"15","author":"Ndrepepa","year":"2014","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2006.01.045","article-title":"Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and\/or healed myocardial infarction","volume":"98","author":"Fisman","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib17","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/eurheartj\/ehq322","article-title":"Multiple marker approach to risk stratification in patients with stable coronary artery disease","volume":"31","author":"Schnabel","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.06.030_bib18","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/ATVBAHA.107.151670","article-title":"Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease","volume":"27","author":"Sabatine","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2017.06.030_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2010.07.006","article-title":"Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease","volume":"160","author":"White","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.06.030_bib20","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"White","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1517\/14622416.2.1.S1","article-title":"Rationale and design of the LURIC study\u2014a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease","volume":"2","author":"Winkelmann","year":"2001","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jacc.2017.06.030_bib22","doi-asserted-by":"crossref","first-page":"e78797","DOI":"10.1371\/journal.pone.0078797","article-title":"GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men","volume":"8","author":"Wallentin","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2017.06.030_bib23","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1515\/cclm-2012-0786","article-title":"High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"51","author":"Giannitsis","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib24","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2017.06.030_bib25","series-title":"Regression Modeling Strategies","first-page":"1","author":"Harrell","year":"2015"},{"key":"10.1016\/j.jacc.2017.06.030_bib26","author":"Chang"},{"key":"10.1016\/j.jacc.2017.06.030_bib27","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/eurheartj\/ehs164","article-title":"Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score","volume":"33","author":"Goliasch","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.06.030_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/joim.12189","article-title":"Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score","volume":"276","author":"Kleber","year":"2014","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","article-title":"An international model to predict recurrent cardiovascular disease","volume":"125","author":"Wilson","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2017.06.030_bib30","doi-asserted-by":"crossref","first-page":"e001646","DOI":"10.1161\/JAHA.114.001646","article-title":"Traditional risk factors versus biomarkers for prediction of secondary events in patients with stable coronary heart disease: from the Heart and Soul Study","volume":"4","author":"Beatty","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2017.06.030_bib31","doi-asserted-by":"crossref","first-page":"e002810","DOI":"10.1161\/JAHA.115.002810","article-title":"Acquisition, analysis, and sharing of data in 2015 and beyond: a survey of the landscape: a conference report from the American Heart Association Data Summit 2015","volume":"4","author":"Antman","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2017.06.030_bib32","first-page":"131","article-title":"Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides","volume":"57","author":"Nishikimi","year":"2011","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib33","first-page":"H2678","article-title":"BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria","volume":"273","author":"Bruneau","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib34","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1161\/01.CIR.102.25.3074","article-title":"Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length","volume":"102","author":"Wiese","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.06.030_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.06.030_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrcardio.2014.64","article-title":"Natriuretic peptides in cardiometabolic regulation and disease","volume":"11","author":"Zois","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-8981(99)00077-7","article-title":"Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB","volume":"284","author":"Apple","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacc.2017.06.030_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/2048872615610869","article-title":"Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease","volume":"5","author":"Biener","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2017.06.030_bib39","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.06.030_bib40","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.103.16.2035","article-title":"Preload induces troponin I degradation independently of myocardial ischemia","volume":"103","author":"Feng","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.06.030_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00424-007-0354-8","article-title":"Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation","volume":"455","author":"Hessel","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jacc.2017.06.030_bib42","first-page":"1","article-title":"High-sensitivity assays for troponin in patients with cardiac disease","volume":"386","author":"Westermann","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib43","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.jacc.2011.01.029","article-title":"Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?","volume":"57","author":"White","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.06.030_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2016.09.025","article-title":"High-sensitivity troponin I is associated with high-risk plaque and MACE in stable coronary artery disease","author":"Brown","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2017.06.030_bib45","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","article-title":"Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure","volume":"116","author":"Latini","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.06.030_bib46","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.06.030_bib47","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2016.5951","article-title":"Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease","volume":"315","author":"Ganz","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.06.030_bib48","doi-asserted-by":"crossref","first-page":"d1745","DOI":"10.1136\/bmj.d1745","article-title":"Salzburg statement on shared decision making","volume":"342","author":"Salzburg Global Seminar","year":"2011","journal-title":"BMJ"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717378531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717378531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T14:20:50Z","timestamp":1535552450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717378531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0735109717378531"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.06.030","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker-Based Risk Model to Predict\u00a0Cardiovascular Mortality in Patients\u00a0With\u00a0Stable\u00a0Coronary\u00a0Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}